Skip to main content
All lobbying filings

KAMRAN DARAVI CONSULTING LLC

KAMRAN DARAVI CONSULTING LLC filed a Q4 report for MONTICELLO GROUP, LLC ON BEHALF OF DETROIT BIOPHARMA on January 30, 2026, reporting $10,000 in lobbying income.

Lobbying for MONTICELLO GROUP, LLC ON BEHALF OF DETROIT BIOPHARMA · Government Relations and Business Development Advisory Firm

All filings by KAMRAN DARAVI CONSULTING LLC · Everything MONTICELLO GROUP, LLC ON BEHALF OF DETROIT BIOPHARMA has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 16, 2026.
 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 30, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Manufacturing

Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.

Health Issues

Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem